speb/financial-data huggingface dataset:
Financial ratios for BBAS3.SA — annual report dated 2024-12-31
Total revenue: 23436338673.13916
Net income: 4720317799.352751
Capital expenditures: 480435598.7055016
Operating cash flow: 20583834627.831715
Depreciation & amortization: 826788996.7637541
Net tangible assets: 27228575889.96764
Owner earnings: 5066671197.411003
Return on net tangible assets (%): 18.60791845260558
Buffett classification: The Gruesome
Stock price: 3.659127625201938
P/E ratio: 4.425300367001289
Shares outstanding: 5708689674
Book value: 29811706148.86731
P/B ratio: 0.7006920028504344
Market cap (USD): 20888824089.838448
Debt to equity: 0.9234963433707739
Effective tax rate (%): -5.272262527512498
COGS to revenue (%): 0
SG&A to revenue (%): 6.079584608785241
Free cash flow (dilution-adjusted): 19654022330.097088
Buyback yield (%): 0
Retained earnings: -2487957443.365696
Receivables turnover: 2.851136259998283
Capitalized R&D asset: 0
FCF margin (%): 83.8613172654948
Revenue growth (%): -9.404704622694336
Rule of 40 score: 74.45661264280047
Financial ratios for BBAS3.SA — quarterly report dated 2025-03-31
Total revenue: 6484512847.222222
Net income: 725321875
Capital expenditures: 165092534.72222224
Operating cash flow: 8399097916.666667
Depreciation & amortization: 253048437.5
Net tangible assets: 29550532465.27778
Owner earnings: 813277777.7777778
Return on net tangible assets (%): 2.7521594703357333
Buffett classification: The Gruesome
Stock price: 4.694444444444445
P/E ratio: 9.236977212760427
Shares outstanding: 5708689674
Book value: 32467918576.388855
P/B ratio: 0.8254032811532115
Market cap (USD): 26799126525.166668
Debt to equity: 2.307209326411425
Effective tax rate (%): -1382.3548195955846
COGS to revenue (%): 0
SG&A to revenue (%): 5.573091699201896
Free cash flow (dilution-adjusted): 8080659722.222222
Buyback yield (%): 0
Retained earnings: -1992317013.888889
Capitalized R&D asset: 0
FCF margin (%): 124.61475383896791
Rule of 40 score: 124.61475383896791
Financial ratios for BBAS3.SA — quarterly report dated 2025-06-30
Total revenue: 6328025364.963503
Net income: 653697445.2554744
Capital expenditures: 114454927.00729926
Operating cash flow: 4375117335.766423
Depreciation & amortization: 256651824.81751823
Net tangible assets: 31025693613.138683
Owner earnings: 795894343.0656934
Return on net tangible assets (%): 2.5652749395057843
Buffett classification: The Gruesome
Stock price: 3.9379562043795615
P/E ratio: 16.301852766240525
Shares outstanding: 5708689674
Book value: 34023382846.715332
P/B ratio: 0.6607388225294047
Market cap (USD): 22480569920.605835
Debt to equity: 2.387148961498344
Effective tax rate (%): -163.1054305777834
COGS to revenue (%): 0
SG&A to revenue (%): 5.796725313494347
Free cash flow (dilution-adjusted): 4077452737.226277
Buyback yield (%): 0
Retained earnings: -1234509306.5693429
Capitalized R&D asset: 0
FCF margin (%): 64.43483554604548
Revenue growth (%): -2.4132496294730013
Rule of 40 score: 62.02158591657248
Financial ratios for BBAS3.SA — quarterly report dated 2025-09-30
Total revenue: 6657805451.127819
Net income: 565177255.6390977
Capital expenditures: 229171804.51127818
Operating cash flow: 7055395864.6616535
Depreciation & amortization: 283461090.2255639
Net tangible assets: 31999183082.706764
Owner earnings: 619466541.3533834
Return on net tangible assets (%): 1.9358823622224284
Buffett classification: The Gruesome
Stock price: 4.056390977443608
P/E ratio: 11.910666634100073
Shares outstanding: 5708689674
Book value: 35178548872.18042
P/B ratio: 0.658261299258755
Market cap (USD): 23156677286.63909
Debt to equity: 2.407080800693008
Effective tax rate (%): -223.52312037659718
COGS to revenue (%): 0
SG&A to revenue (%): 5.612500449963685
Free cash flow (dilution-adjusted): 6720953007.518797
Buyback yield (%): 0
Retained earnings: -829646804.5112782
Capitalized R&D asset: 0
FCF margin (%): 100.94847404080095
Revenue growth (%): 5.211421685984632
Rule of 40 score: 106.15989572678558
Financial ratios for BBAS3.SA — quarterly report dated 2025-12-31
Total revenue: 7484603102.18978
Net income: 1097642153.2846715
Capital expenditures: 221538138.68613136
Operating cash flow: 9008200000
Depreciation & amortization: 293111678.8321168
Net tangible assets: 32327468430.656933
Owner earnings: 1169215693.430657
Return on net tangible assets (%): 3.616787055066338
Buffett classification: The Gruesome
Stock price: 3.865350089766607
P/E ratio: 7.254192647418728
Shares outstanding: 5708689674
Book value: 35322521167.88318
P/B ratio: 0.6247029774281536
Market cap (USD): 22066084143.8456
Debt to equity: 0.8443180436938836
Effective tax rate (%): -97.80646527613122
COGS to revenue (%): 0
SG&A to revenue (%): 6.841748723809523
Free cash flow (dilution-adjusted): 8621002189.781021
Buyback yield (%): 0
Retained earnings: -1265702372.2627735
Receivables turnover: 0.7585804657677817
Capitalized R&D asset: 0
FCF margin (%): 115.18315763809524
Revenue growth (%): 12.418471178395627
Rule of 40 score: 127.60162881649086
Financial ratios for BBAS3.SA — annual report dated 2025-12-31
Total revenue: 26846647262.77372
Net income: 3062397445.255474
Capital expenditures: 732001642.3357663
Operating cash flow: 29060965145.985397
Depreciation & amortization: 1090926277.3722627
Net tangible assets: 32327468430.656933
Owner earnings: 3421322080.2919707
Return on net tangible assets (%): 10.583328192341368
Buffett classification: The Gruesome
Stock price: 3.865350089766607
P/E ratio: 7.205493257588839
Shares outstanding: 5708689674
Book value: 35322521167.88318
P/B ratio: 0.6247029774281536
Market cap (USD): 22066084143.8456
Debt to equity: 0.8443180436938836
Effective tax rate (%): -198.94952219915933
COGS to revenue (%): 0
SG&A to revenue (%): 5.936074729172607
Free cash flow (dilution-adjusted): 27716715875.912407
Buyback yield (%): 0
Retained earnings: -1265702372.2627735
Receivables turnover: 2.7209648804142885
Capitalized R&D asset: 0
FCF margin (%): 103.2408836925613
Revenue growth (%): 14.551371002089079
Rule of 40 score: 117.79225469465038
Financial ratios for BEMO.L — annual report dated 2021-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.09256756756756755
Shares outstanding: 11492905
Market cap (USD): 1063870.260135135
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BEMO.L — annual report dated 2022-09-30
Total revenue: -34931111.11111111
Net income: -36368888.88888889
Capital expenditures: 0
Net tangible assets: 83786666.66666667
Owner earnings: -36368888.88888889
Return on net tangible assets (%): -43.406535115637595
Buffett classification: The Gruesome
Stock price: 0.05388888888888888
Shares outstanding: 11492905
Book value: 83786666.66666667
P/B ratio: 0.0073918668112136635
Market cap (USD): 619339.8805555555
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BEMO.L — annual report dated 2023-09-30
Total revenue: 1148780.487804878
Net income: 206097.56097560975
Capital expenditures: 0
Net tangible assets: 88856097.56097561
Owner earnings: 206097.56097560975
Return on net tangible assets (%): 0.23194532129230597
Buffett classification: The Gruesome
Stock price: 0.05390243902439024
P/E ratio: 3.0058366923076925
Shares outstanding: 11492905
Book value: 88856097.56097561
P/B ratio: 0.0069718975734951
Market cap (USD): 619495.6109756097
Debt to equity: 0
Effective tax rate (%): 43.47826086956522
COGS to revenue (%): 0
SG&A to revenue (%): 68.25902335456476
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BEMO.L — annual report dated 2024-09-30
Total revenue: 17778666.666666668
Net income: 16622666.666666666
Capital expenditures: 0
Net tangible assets: 111110666.66666667
Owner earnings: 16622666.666666666
Return on net tangible assets (%): 14.960459841839366
Buffett classification: The Gruesome
Stock price: 0.06999999999999999
P/E ratio: 0.04839797164514318
Shares outstanding: 11492905
Book value: 111110666.66666667
P/B ratio: 0.007240559112236448
Market cap (USD): 804503.3499999999
Debt to equity: 0
Effective tax rate (%): 1.2123613312202852
COGS to revenue (%): 0
SG&A to revenue (%): 5.35473226338683
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 1447.6121726822364
Rule of 40 score: 1447.6121726822364
Financial ratios for BEMO.L — annual report dated 2025-09-30
Total revenue: 32240540.540540542
Net income: 31094594.594594594
Capital expenditures: 0
Net tangible assets: 140035135.13513514
Owner earnings: 31094594.594594594
Return on net tangible assets (%): 22.204852064153783
Buffett classification: The Gruesome
Stock price: 0.10486486486486486
P/E ratio: 0.038759210256410256
Shares outstanding: 11492905
Book value: 140035135.13513514
P/B ratio: 0.008606425298670218
Market cap (USD): 1205201.9297297297
Debt to equity: 0
Effective tax rate (%): 0.5403068943159716
COGS to revenue (%): 0
SG&A to revenue (%): 3.0304300444295413
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): 81.34397334187344
Rule of 40 score: 81.34397334187344
Financial ratios for BEMO.L — quarterly report dated 2025-09-30
Capital expenditures: 0
Net tangible assets: 140035135.13513514
Buffett classification: The Gruesome
Stock price: 0.10486486486486486
Shares outstanding: 11492905
Book value: 140035135.13513514
P/B ratio: 0.008606425298670218
Market cap (USD): 1205201.9297297297
Debt to equity: 0
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRBI — quarterly report dated 2025-09-30
Total revenue: 934880075.1879699
Gross profit: 20121052.631578945
Operating income: 12097932.330827067
Net income: 7936842.105263158
Capital expenditures: 50375.93984962406
Operating cash flow: 20657706.766917292
Depreciation & amortization: 460338.3458646616
Net tangible assets: 149721804.51127818
Owner earnings: 8346804.511278195
Return on net tangible assets (%): 5.57487570933561
Capex to operating income (%): 0.4164012367738227
Buffett classification: The Great
Stock price: 12.55
P/E ratio: 13.917253302744905
Shares outstanding: 26248926
Book value: 152181390.9774437
P/B ratio: 2.1646800517733946
Market cap (USD): 329424021.3
Debt to equity: 15.923210701514927
Current ratio: 0.34597678921642466
Quick ratio: 0.34597678921642466
Effective tax rate (%): 34.395052904709374
COGS to revenue (%): 97.84773970848256
SG&A to revenue (%): 0.532998281714393
Free cash flow (dilution-adjusted): 20607330.82706767
Buyback yield (%): 0
Retained earnings: 17432518.79699248
Receivables turnover: 11.773583565716775
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2134927893893055
FCF margin (%): 2.204275326214894
Revenue growth (%): 61.14469660725088
Rule of 40 score: 63.348971933465776
Financial ratios for BRBI — annual report dated 2025-12-31
Total revenue: 2267837043.7956204
Gross profit: 73878284.67153284
Operating income: 42454562.043795615
Net income: 31947627.737226274
Capital expenditures: 104379.56204379561
Operating cash flow: -77493613.13868612
Depreciation & amortization: 1977554.7445255474
Net tangible assets: 140696167.88321167
Owner earnings: 33820802.91970803
Return on net tangible assets (%): 24.038183433525937
Capex to operating income (%): 0.24586182737233023
Buffett classification: The Great
Stock price: 13.73
P/E ratio: 11.280892495190008
Shares outstanding: 26248926
Book value: 142937591.24087572
P/B ratio: 2.5213644000245155
Market cap (USD): 360397753.98
Debt to equity: 17.458416847738686
Current ratio: 0.28374848386404183
Quick ratio: 0.28374848386404183
Effective tax rate (%): 24.748657860916133
COGS to revenue (%): 96.74234597791538
SG&A to revenue (%): 0.818346237656753
Free cash flow (dilution-adjusted): -77597992.70072992
Buyback yield (%): 0
Receivables turnover: 39.39188880788615
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.621452326713103
FCF margin (%): -3.4216740974852478
Revenue growth (%): 89.02636156610943
Rule of 40 score: 85.60468746862418
Financial ratios for BRBI — quarterly report dated 2025-12-31
Total revenue: 424957664.2335766
Gross profit: 18223722.627737224
Operating income: 9157481.751824817
Net income: 16781204.379562043
Capital expenditures: 101277.37226277372
Operating cash flow: -60470620.4379562
Depreciation & amortization: 636678.8321167883
Net tangible assets: 140696167.88321167
Owner earnings: 17316605.83941606
Return on net tangible assets (%): 12.307802053137749
Capex to operating income (%): 1.1059522148934897
Buffett classification: The Great
Stock price: 13.73
P/E ratio: 8.909402631178061
Shares outstanding: 26248926
Book value: 142937591.24087572
P/B ratio: 2.5213644000245155
Market cap (USD): 360397753.98
Debt to equity: 17.458416847738686
Current ratio: 0.28374848386404183
Quick ratio: 0.28374848386404183
Effective tax rate (%): 11.256800111591575
COGS to revenue (%): 95.71163808503037
SG&A to revenue (%): 1.4815559128260092
Free cash flow (dilution-adjusted): -60369343.06569342
Buyback yield (%): 0
Receivables turnover: 7.381432058068402
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.2125515992256368
FCF margin (%): -14.205966416577349
Revenue growth (%): -54.544152184638946
Rule of 40 score: -68.7501186012163
Financial ratios for BRM.V — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.7086614173228346
Shares outstanding: 16234737
Market cap (USD): 11504931.732283464
Buyback yield (%): 84.94211448506303
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRM.V — annual report dated 2022-12-31
Total revenue: 21222773.529411763
Gross profit: 6442382.352941176
Operating income: 1941608.088235294
Net income: 1186071.3235294116
Capital expenditures: 149477.20588235292
Operating cash flow: 1062436.7647058822
Depreciation & amortization: 257829.41176470587
Net tangible assets: 3323936.0294117643
Owner earnings: 1294423.5294117643
Return on net tangible assets (%): 38.942492212789006
Capex to operating income (%): 7.698629130568316
Buffett classification: The Great
Stock price: 0.6470588235294117
P/E ratio: 8.856828097209213
Shares outstanding: 16234737
Book value: 3323936.029411765
P/B ratio: 3.1603586021444716
Market cap (USD): 10504829.823529411
Debt to equity: 1.0499060623777665
Current ratio: 1.3755457143244085
Quick ratio: 1.3068212887885418
Effective tax rate (%): 32.321406993683
Interest coverage ratio: 10.267506289393769
COGS to revenue (%): 69.64401309747312
R&D to revenue (%): 0.33649687911556714
SG&A to revenue (%): 20.04580124319838
Free cash flow (dilution-adjusted): 844067.6470588235
Buyback yield (%): 0
Retained earnings: -3011748.5294117643
Inventory turnover: 22.635488066483116
Receivables turnover: 2.357916424309363
Capitalized R&D asset: 71413.97058823529
ROCI (R&D-adjusted, %): 34.22154526925494
FCF margin (%): 3.9771787881026253
Rule of 40 score: 3.9771787881026253
Financial ratios for BRM.V — annual report dated 2023-12-31
Total revenue: 19064733.333333332
Gross profit: 5319706.060606061
Operating income: 2337937.878787879
Net income: 1651050
Capital expenditures: 418842.4242424242
Operating cash flow: 371237.1212121212
Depreciation & amortization: 289928.78787878784
Net tangible assets: 5090746.212121212
Owner earnings: 1522136.3636363638
Return on net tangible assets (%): 29.90006376692112
Capex to operating income (%): 17.915036496161143
Buffett classification: The Great
Stock price: 0.7575757575757576
P/E ratio: 7.449225148734552
Shares outstanding: 16234737
Book value: 5090746.212121213
P/B ratio: 2.41596077850705
Market cap (USD): 12299043.181818182
Debt to equity: 0.6228144204018431
Current ratio: 1.413015679695666
Quick ratio: 1.3481585244387033
Effective tax rate (%): 21.861356618038545
Interest coverage ratio: 11.286331303600491
COGS to revenue (%): 72.09661437380332
R&D to revenue (%): 0.12095949970769447
SG&A to revenue (%): 15.519270707996139
Free cash flow (dilution-adjusted): -144309.84848484848
Buyback yield (%): 0
Retained earnings: -1451963.6363636362
Inventory turnover: 20.133892773478898
Receivables turnover: 1.7837526382801883
Capitalized R&D asset: 70907.9663547237
ROCI (R&D-adjusted, %): 29.9253491955196
Rosenberg metric: -15.720681584956777
FCF margin (%): -0.7569465880361042
Revenue growth (%): -10.168511637216938
Rule of 40 score: -10.925458225253042
Financial ratios for BRM.V — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.7407407407407407
Shares outstanding: 16234737
Market cap (USD): 28260468.111111112
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRM.V — quarterly report dated 2024-12-31
Capital expenditures: 3629.3706293706296
Buffett classification: The Gruesome
Stock price: 2.132867132867133
Shares outstanding: 16234737
Market cap (USD): 34626536.95804196
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRM.V — annual report dated 2024-12-31
Total revenue: 26167104.195804197
Gross profit: 7032108.391608392
Operating income: 3072555.944055944
Net income: 2128484.6153846155
Capital expenditures: 260140.55944055945
Operating cash flow: 2576990.20979021
Depreciation & amortization: 330857.34265734267
Net tangible assets: 7430127.972027972
Owner earnings: 2199201.398601399
Return on net tangible assets (%): 29.598432313422872
Capex to operating income (%): 8.46658495978952
Buffett classification: The Great
Stock price: 2.132867132867133
P/E ratio: 16.268164076809626
Shares outstanding: 16234737
Book value: 7430127.9720279705
P/B ratio: 4.660288098455326
Market cap (USD): 34626536.95804196
Debt to equity: 0.33474345565112296
Current ratio: 1.6328725316597796
Quick ratio: 1.439513871124233
Effective tax rate (%): 26.63026945251834
Interest coverage ratio: 22.477209478401438
COGS to revenue (%): 73.12614976808949
R&D to revenue (%): 0.11721063645837929
SG&A to revenue (%): 15.014583917206249
Free cash flow (dilution-adjusted): 2216800.6993006994
Buyback yield (%): 0
Retained earnings: 788210.4895104895
Inventory turnover: 9.42242549501831
Receivables turnover: 2.516801496186624
Capitalized R&D asset: 69687.84572535308
ROCI (R&D-adjusted, %): 32.21140264524368
Rosenberg metric: 74.2566056807844
FCF margin (%): 8.471708152009253
Revenue growth (%): 37.25397433203471
Rule of 40 score: 45.72568248404396
Financial ratios for BRM.V — quarterly report dated 2025-03-31
Total revenue: 3307972.027972028
Gross profit: 776109.0909090909
Operating income: 51084.61538461539
Net income: 25988.81118881119
Capital expenditures: 63520.97902097902
Operating cash flow: 3283269.9300699304
Depreciation & amortization: 93996.5034965035
Net tangible assets: 7477262.237762238
Owner earnings: 56464.33566433567
Return on net tangible assets (%): 0.7551471898253774
Capex to operating income (%): 124.34463593927529
Buffett classification: The Gruesome
Stock price: 1.5664335664335667
P/E ratio: 244.63062964158865
Shares outstanding: 16234737
Book value: 7477262.237762237
P/B ratio: 3.401062604249621
Market cap (USD): 25430636.979020983
Debt to equity: 0.31517378794545897
Current ratio: 1.650796650033738
Quick ratio: 1.4282688886841288
Effective tax rate (%): 26.499614342503413
Interest coverage ratio: 1.676173649671883
COGS to revenue (%): 76.5382208692711
R&D to revenue (%): 0.295704380179266
SG&A to revenue (%): 21.621786741078978
Free cash flow (dilution-adjusted): 3192958.7412587414
Buyback yield (%): 0
Retained earnings: 814199.3006993007
Inventory turnover: 1.1007099080989597
Receivables turnover: 0.4986279929907055
Capitalized R&D asset: 9781.818181818182
ROCI (R&D-adjusted, %): 0.6145032300775745
FCF margin (%): 96.52314814814814
Rule of 40 score: 96.52314814814814
Financial ratios for BRM.V — quarterly report dated 2025-06-30
Total revenue: 6883670.0729927
Gross profit: 1861284.6715328465
Operating income: 772115.3284671532
Net income: 543613.1386861313
Capital expenditures: 181816.05839416056
Operating cash flow: -975340.8759124087
Depreciation & amortization: 79706.56934306568
Net tangible assets: 7988776.642335766
Owner earnings: 441503.6496350365
Return on net tangible assets (%): 5.526548924842005
Capex to operating income (%): 23.54778511587278
Buffett classification: The Great
Stock price: 1.6277372262773722
P/E ratio: 46.393601320228086
Shares outstanding: 16234737
Book value: 7988776.642335767
P/B ratio: 3.3078764067180377
Market cap (USD): 26425885.773722626
Debt to equity: 0.28693685593950047
Current ratio: 1.7319978624983046
Quick ratio: 1.600089715436317
Effective tax rate (%): 26.499977794555225
Interest coverage ratio: 26.089480823776054
COGS to revenue (%): 72.96086750532413
R&D to revenue (%): 0.16652125393982248
SG&A to revenue (%): 15.655988127195771
Free cash flow (dilution-adjusted): -1185120.4379562042
Buyback yield (%): 0
Retained earnings: 1393470.802919708
Inventory turnover: 3.81214382354147
Receivables turnover: 0.7741476528798756
Capitalized R&D asset: 18016.59190444592
ROCI (R&D-adjusted, %): 7.913509373465212
Rosenberg metric: 110.93802404146201
FCF margin (%): -17.21640382803775
Revenue growth (%): 108.09335794815578
Rule of 40 score: 90.87695412011803
Financial ratios for BRM.V — quarterly report dated 2025-09-30
Total revenue: 8095658.992805756
Gross profit: 2277613.6690647486
Operating income: 1147826.6187050361
Net income: 832761.8705035972
Capital expenditures: 226.61870503597123
Operating cash flow: 648549.6402877698
Depreciation & amortization: 95346.76258992807
Net tangible assets: 8773828.057553958
Owner earnings: 927882.0143884893
Return on net tangible assets (%): 10.575566426670688
Capex to operating income (%): 0.019743287125684513
Buffett classification: The Great
Stock price: 1.4100719424460433
P/E ratio: 16.323971571450965
Shares outstanding: 16234737
Book value: 8773828.057553956
P/B ratio: 2.609140159406397
Market cap (USD): 22892147.13669065
Debt to equity: 0.2529271777140336
Current ratio: 1.8874437269869848
Quick ratio: 1.7305095938323791
Effective tax rate (%): 26.500000317483895
Interest coverage ratio: 41.5446047286741
COGS to revenue (%): 71.86623508859797
R&D to revenue (%): 0.4366759839139299
SG&A to revenue (%): 13.518791401306999
Free cash flow (dilution-adjusted): 648776.2589928058
Buyback yield (%): 0
Retained earnings: 2145263.309352518
Inventory turnover: 3.9114404226072845
Receivables turnover: 0.9271571773865572
Capitalized R&D asset: 46259.85695531167
ROCI (R&D-adjusted, %): 11.032185215569847
Rosenberg metric: 36.32009211784933
FCF margin (%): 8.013878296619755
Revenue growth (%): 17.606725873864246
Rule of 40 score: 25.620604170484
Financial ratios for BRM.V — quarterly report dated 2025-12-31
Total revenue: 12365952.554744525
Gross profit: 4336801.459854014
Operating income: 2809051.8248175182
Net income: 2100105.109489051
Capital expenditures: 20597.0802919708
Operating cash flow: 2465865.6934306566
Depreciation & amortization: 69276.64233576642
Net tangible assets: 10894732.846715327
Owner earnings: 2148784.671532847
Return on net tangible assets (%): 19.72315156108383
Capex to operating income (%): 0.7332395974328039
Buffett classification: The Great
Stock price: 1.9708029197080292
P/E ratio: 9.13511803272486
Shares outstanding: 16234737
Book value: 10894732.846715327
P/B ratio: 2.936783079535387
Market cap (USD): 31995467.08029197
Debt to equity: 0.18972303230436674
Current ratio: 1.8519824748938085
Quick ratio: 1.7689941203060175
Effective tax rate (%): 22.02521573434505
Interest coverage ratio: 97.56372163772342
COGS to revenue (%): 64.92949944086527
R&D to revenue (%): -0.18103628664885424
SG&A to revenue (%): 12.535520328804866
Free cash flow (dilution-adjusted): 2454421.897810219
Buyback yield (%): 0
Retained earnings: 4276686.131386861
Inventory turnover: 8.035773275933233
Receivables turnover: 1.1148193840924707
Capitalized R&D asset: 5081.559050569767
ROCI (R&D-adjusted, %): 22.275445056682813
Rosenberg metric: 58.24845904876125
FCF margin (%): 19.84822347445054
Revenue growth (%): 52.747942641032495
Rule of 40 score: 72.59616611548303
Financial ratios for BRM.V — annual report dated 2025-12-31
Total revenue: 30916313.868613135
Gross profit: 9319049.635036496
Operating income: 4799073.722627737
Net income: 3515764.233576642
Capital expenditures: 268486.1313868613
Operating cash flow: 5575605.109489051
Depreciation & amortization: 343835.03649635037
Net tangible assets: 10894732.846715327
Owner earnings: 3591113.138686131
Return on net tangible assets (%): 32.961920124262825
Capex to operating income (%): 5.594540673983469
Buffett classification: The Great
Stock price: 1.9708029197080292
P/E ratio: 9.100572437345289
Shares outstanding: 16234737
Book value: 10894732.846715327
P/B ratio: 2.936783079535387
Market cap (USD): 31995467.08029197
Debt to equity: 0.18972303230436674
Current ratio: 1.8519824748938085
Quick ratio: 1.7689941203060175
Effective tax rate (%): 23.890998113154183
Interest coverage ratio: 40.59052211116393
COGS to revenue (%): 69.85717742858931
R&D to revenue (%): 0.11370700513630512
SG&A to revenue (%): 14.506328008150094
Free cash flow (dilution-adjusted): 5260345.255474452
Buyback yield (%): 0.22845389419544576
Retained earnings: 4276686.131386861
Inventory turnover: 21.615076950275082
Receivables turnover: 2.7871776017928336
Capitalized R&D asset: 63313.336276861824
ROCI (R&D-adjusted, %): 38.33954025740371
Rosenberg metric: 74.56453585586058
FCF margin (%): 17.014787978378173
Revenue growth (%): 18.149542407411122
Rule of 40 score: 35.1643303857893
Financial ratios for CAMLINFINE.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.838981933271792
Shares outstanding: 192091613
Market cap (USD): 353253005.8400369
Buyback yield (%): 0
Retained earnings: 30651061.585124623
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAMLINFINE.NS — annual report dated 2023-03-31
Total revenue: 203568952.49695495
Gross profit: 102427710.10962242
Operating income: 19731157.12545676
Net income: 7031571.254567601
Capital expenditures: 17467454.32399513
Operating cash flow: 6199537.149817296
Depreciation & amortization: 7614141.291108405
Net tangible assets: 91738465.2862363
Owner earnings: -2821741.7783191223
Return on net tangible assets (%): -3.0758545714874455
Capex to operating income (%): 88.52726787857237
Buffett classification: The Gruesome
Stock price: 1.5523751522533498
P/E ratio: 42.40847972403914
Shares outstanding: 192091613
Book value: 100375688.18514007
P/B ratio: 2.9708214446056744
Market cap (USD): 298198246.9774665
Debt to equity: 0.9714343579371241
Current ratio: 1.3717986080731956
Quick ratio: 0.6553381511502521
Effective tax rate (%): 50.470408201351134
Interest coverage ratio: 3.938910137795036
COGS to revenue (%): 49.684021628418726
SG&A to revenue (%): 3.402869776128311
Free cash flow (dilution-adjusted): -11664993.909866016
Buyback yield (%): 0
Retained earnings: 36862935.44457978
Inventory turnover: 1.4615480338695883
Receivables turnover: 5.487071590593091
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.78441456932444
FCF margin (%): -5.730242144877424
Rule of 40 score: -5.730242144877424
Financial ratios for CAMLINFINE.NS — annual report dated 2024-03-31
Total revenue: 172230759.083823
Gross profit: 77158208.41827556
Operating income: 19636011.512171723
Net income: -11122844.46576328
Capital expenditures: 7197217.891833553
Operating cash flow: 16666482.791701643
Depreciation & amortization: 9426322.10097134
Net tangible assets: 96517759.9232522
Owner earnings: -8893740.256625494
Return on net tangible assets (%): -9.214615282925658
Capex to operating income (%): 36.65315579679831
Buffett classification: The Good
Stock price: 1.0706573896353166
Shares outstanding: 192091613
Book value: 102764168.36551146
P/B ratio: 2.00132310917859
Market cap (USD): 205664304.94541746
Debt to equity: 0.7970489307199109
Current ratio: 1.3665184163103796
Quick ratio: 0.6663658233220644
Effective tax rate (%): 9.611534660816048
Interest coverage ratio: 2.4215424430641823
COGS to revenue (%): 55.20068027992407
SG&A to revenue (%): 3.400195079862777
Free cash flow (dilution-adjusted): 9401271.135627773
Buyback yield (%): 0
Retained earnings: 27439501.139225326
Inventory turnover: 1.5463305247607735
Receivables turnover: 5.036732390770383
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.42775902432016
FCF margin (%): 5.458532021595671
Revenue growth (%): -15.394387517713792
Rule of 40 score: -9.935855496118121
Financial ratios for CAMLINFINE.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 71201457.23841377
Buffett classification: The Gruesome
Stock price: 1.2273053033922598
Shares outstanding: 192091613
Book value: 79466829.9092212
P/B ratio: 2.966710206527528
Market cap (USD): 235755055.37207356
Debt to equity: 1.1527011348176748
Current ratio: 1.2006242894445704
Quick ratio: 0.6113611273421141
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAMLINFINE.NS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.491782259004546
Shares outstanding: 192091613
Market cap (USD): 286558860.376967
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CAMLINFINE.NS — quarterly report dated 2025-03-31
Total revenue: 50454079.9625906
Gross profit: 25810872.106616784
Operating income: 5250315.641805003
Net income: 12859.480944587327
Capital expenditures: 0
Depreciation & amortization: 2004161.7956511572
Net tangible assets: 98664893.61702126
Owner earnings: 2017021.2765957445
Return on net tangible assets (%): 2.0443150574154942
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.957637997432606
P/E ratio: 7310.6730010591955
Shares outstanding: 192091613
Book value: 102265524.90063128
P/B ratio: 3.677151620375615
Market cap (USD): 376045840.5969191
Debt to equity: 0.7451039365014694
Current ratio: 1.3984609048683456
Quick ratio: 0.7758509545190535
Effective tax rate (%): 20.59618637716537
Interest coverage ratio: 4.8823420700751194
COGS to revenue (%): 48.842844571233144
Buyback yield (%): 0
Retained earnings: 11647802.197802197
Inventory turnover: 0.40010272184416457
Receivables turnover: 1.314923526902687
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.81387075629049
Rule of 40 score: 0
Financial ratios for CAMLINFINE.NS — annual report dated 2025-03-31
Total revenue: 186785118.07341594
Gross profit: 76382253.91629647
Operating income: 19431739.537058685
Net income: -16255073.6497545
Capital expenditures: 4962216.506897357
Operating cash flow: 2688321.25321487
Depreciation & amortization: 8612228.19733458
Net tangible assets: 98664893.61702126
Owner earnings: -12605061.959317278
Return on net tangible assets (%): -12.775630213767041
Capex to operating income (%): 25.536656136388658
Buffett classification: The Good
Stock price: 1.957637997432606
Shares outstanding: 192091613
Book value: 102265524.90063128
P/B ratio: 3.677151620375615
Market cap (USD): 376045840.5969191
Debt to equity: 0.7451039365014694
Current ratio: 1.3984609048683456
Quick ratio: 0.7758509545190535
Effective tax rate (%): -0.793320191338362
Interest coverage ratio: 2.2447631587832135
COGS to revenue (%): 59.10688458259592
SG&A to revenue (%): 3.542178020614987
Free cash flow (dilution-adjusted): -2306616.7874678513
Buyback yield (%): 0
Retained earnings: 11647802.197802197
Inventory turnover: 1.7924811861677787
Receivables turnover: 4.867954116141612
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.115369097840283
FCF margin (%): -1.2349039427012785
Revenue growth (%): 8.45049924125892
Rule of 40 score: 7.215595298557641
Financial ratios for CAMLINFINE.NS — quarterly report dated 2025-06-30
Total revenue: 49561432.249005385
Gross profit: 21843131.28949216
Operating income: 246747.01614790547
Net income: -1165539.4336531712
Capital expenditures: 0
Depreciation & amortization: 1979908.7292300493
Owner earnings: 814369.2955768781
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.6718932834074427
Shares outstanding: 192091613
Market cap (USD): 705339903.5736018
Interest coverage ratio: 0.1415082944113384
COGS to revenue (%): 55.92715888485947
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -1.7692280074219378
Rule of 40 score: -1.7692280074219378
Financial ratios for CAMLINFINE.NS — quarterly report dated 2025-09-30
Total revenue: 51839560.315670796
Gross profit: 24024904.171364147
Operating income: 1966516.3472378803
Net income: -1621645.9977452084
Capital expenditures: 0
Depreciation & amortization: 2122581.7361894026
Net tangible assets: 92589346.11048478
Owner earnings: 500935.7384441942
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 2.200901916572717
Shares outstanding: 192091613
Book value: 96969549.04171365
P/B ratio: 4.359871767861666
Market cap (USD): 422774799.2092446
Debt to equity: 0.780951469673007
Current ratio: 1.3626937771660532
Quick ratio: 0.7426966427274353
Interest coverage ratio: 1.14716579087555
COGS to revenue (%): 53.655270173845295
Buyback yield (%): 0
Inventory turnover: 0.46466802686725767
Receivables turnover: 1.4114814485110614
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.4775329105356914
Revenue growth (%): 4.59657431855418
Rule of 40 score: 4.59657431855418
Financial ratios for CAMLINFINE.NS — quarterly report dated 2025-12-31
Total revenue: 50929787.234042555
Gross profit: 23301927.14715384
Operating income: 14335535.256767295
Net income: -4035858.304556088
Capital expenditures: 0
Depreciation & amortization: 1863395.34365601
Owner earnings: -2172462.960900078
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 1.6531135123092349
Shares outstanding: 192091613
Market cap (USD): 317549241.05157626
Interest coverage ratio: 6.8092161655925585
COGS to revenue (%): 54.246957600525114
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -1.7549783911906012
Rule of 40 score: -1.7549783911906012
Financial ratios for CARERATING.NS — annual report dated 2022-03-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.095344850323091
Shares outstanding: 30087146
Market cap (USD): 183391530.432019
Buyback yield (%): 0
Retained earnings: 40103666.09521297
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CARERATING.NS — annual report dated 2023-03-31
Total revenue: 33982095.006090134
Gross profit: 18865042.63093788
Operating income: 11526833.130328868
Net income: 10409013.398294764
Capital expenditures: 1398306.9427527406
Operating cash flow: 10017344.701583436
Depreciation & amortization: 1282509.1352009745
Net tangible assets: 80151766.13885505
Owner earnings: 10293215.590742998
Return on net tangible assets (%): 12.842156931278362
Capex to operating income (%): 12.130885620904673
Buffett classification: The Great
Stock price: 7.344092570036542
P/E ratio: 21.22802391900115
Shares outstanding: 30087146
Book value: 82709037.7588307
P/B ratio: 2.6715675986523357
Market cap (USD): 220962785.39220467
Debt to equity: 0.02573938076216878
Current ratio: 10.409763725590254
Quick ratio: 10.409763725590254
Effective tax rate (%): 32.039460342832605
Interest coverage ratio: 94.48412539936102
COGS to revenue (%): 44.48534551046084
SG&A to revenue (%): 4.231969977741377
Free cash flow (dilution-adjusted): 8557028.014616322
Buyback yield (%): 0.10198971627959229
Retained earnings: 40031352.00974422
Receivables turnover: 13.689011226252159
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.295050564864006
FCF margin (%): 25.1809902040553
Rule of 40 score: 25.1809902040553
Financial ratios for CARERATING.NS — annual report dated 2024-03-31
Total revenue: 39775128.912339605
Gross profit: 21790106.72742535
Operating income: 12320494.064036455
Net income: 12299292.481112843
Capital expenditures: 1099796.1386257345
Operating cash flow: 10898381.10085142
Depreciation & amortization: 1257093.176639885
Net tangible assets: 83963364.91185993
Owner earnings: 12456589.519126993
Return on net tangible assets (%): 14.835743579599539
Capex to operating income (%): 8.926558731407058
Buffett classification: The Great
Stock price: 12.968570057581573
P/E ratio: 31.72436636764824
Shares outstanding: 30087146
Book value: 86891042.09137785
P/B ratio: 4.490534942869597
Market cap (USD): 390187260.7336852
Debt to equity: 0.026986504263685505
Current ratio: 8.573609280487664
Quick ratio: 8.573609280487664
Effective tax rate (%): 30.052411008698797
Interest coverage ratio: 60.01203271028037
COGS to revenue (%): 45.21675397847596
SG&A to revenue (%): 4.641876866229625
Free cash flow (dilution-adjusted): 9473018.347523684
Buyback yield (%): 0
Retained earnings: 43415169.684614465
Receivables turnover: 14.75131531547558
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.46392504278054
FCF margin (%): 23.816436568694137
Revenue growth (%): 17.047312430888287
Rule of 40 score: 40.86374899958243
Financial ratios for CARERATING.NS — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 88005542.28380315
Buffett classification: The Gruesome
Stock price: 11.78451982799809
Shares outstanding: 30087146
Book value: 91071201.6244625
P/B ratio: 3.8932457492647696
Market cap (USD): 354562568.6048734
Debt to equity: 0.02721522946938946
Current ratio: 7.793588183593124
Quick ratio: 7.793588183593124
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CARERATING.NS — annual report dated 2025-03-31
Total revenue: 47032674.77203647
Gross profit: 26719604.863221884
Operating income: 16880091.185410332
Net income: 16366834.229600186
Capital expenditures: 59885071.311667055
Operating cash flow: 14373848.491933597
Depreciation & amortization: 1370317.9798924478
Net tangible assets: 91850280.57049333
Owner earnings: -42147919.102174416
Return on net tangible assets (%): -45.88763239522899
Capex to operating income (%): 354.767463361966
Buffett classification: The Gruesome
Stock price: 12.652934998249505
P/E ratio: 23.259886260248525
Shares outstanding: 30087146
Book value: 95335807.80921206
P/B ratio: 3.993155471894553
Market cap (USD): 380690702.6208426
Debt to equity: 0.0291464465161051
Current ratio: 7.076634510682024
Quick ratio: 7.076634510682024
Effective tax rate (%): 27.183149577303915
Interest coverage ratio: 68.49079783701735
COGS to revenue (%): 43.189272154455125
SG&A to revenue (%): 4.447730958757698
Free cash flow (dilution-adjusted): 12431552.490063127
Buyback yield (%): 0
Retained earnings: 52071744.21323357
Receivables turnover: 12.538997609497184
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 16.79097964659615
FCF margin (%): 26.431736128803742
Revenue growth (%): 18.246442081160236
Rule of 40 score: 44.678178209963974
Financial ratios for CARERATING.NS — quarterly report dated 2025-03-31
Total revenue: 12818669.628244095
Gross profit: 7310474.631751227
Operating income: 5179787.234042553
Net income: 5070388.122515782
Capital expenditures: 0
Depreciation & amortization: 357902.73556231003
Net tangible assets: 91850280.57049333
Owner earnings: 5428290.858078091
Return on net tangible assets (%): 5.909933888456641
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 12.652934998249505
P/E ratio: 18.77029398056981
Shares outstanding: 30087146
Book value: 95335807.80921206
P/B ratio: 3.993155471894553
Market cap (USD): 380690702.6208426
Debt to equity: 0.0291464465161051
Current ratio: 7.076634510682024
Quick ratio: 7.076634510682024
Effective tax rate (%): 26.344650268658338
Interest coverage ratio: 74.29225352112677
COGS to revenue (%): 42.970098740639614
Buyback yield (%): 0
Retained earnings: 52071744.21323357
Receivables turnover: 3.417480902469355
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 5.15244266545666
Rule of 40 score: 0
Financial ratios for CARERATING.NS — quarterly report dated 2025-06-30
Total revenue: 10988181.60542944
Gross profit: 4704493.330212966
Operating income: 2848326.702550901
Net income: 3100561.6662766207
Capital expenditures: 0
Depreciation & amortization: 397320.38380528905
Owner earnings: 3497882.0500819096
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 20.641937748654342
P/E ratio: 50.07616857952101
Shares outstanding: 30087146
Market cap (USD): 621056994.7666745
Effective tax rate (%): 29.22684088365621
Interest coverage ratio: 40.61027694361027
COGS to revenue (%): 57.18587934614771
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -14.279859579042716
Rule of 40 score: -14.279859579042716
Financial ratios for CARERATING.NS — quarterly report dated 2025-09-30
Total revenue: 15374419.391206313
Gross profit: 9367655.016910935
Operating income: 7322266.065388951
Net income: 6449819.616685457
Capital expenditures: 0
Depreciation & amortization: 390090.1916572717
Net tangible assets: 95009368.65839909
Owner earnings: 6839909.808342729
Return on net tangible assets (%): 7.199195095101879
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 16.957271702367528
P/E ratio: 34.89528459970437
Shares outstanding: 30087146
Book value: 98389289.740699
P/B ratio: 5.1854821883093285
Market cap (USD): 510195909.47080034
Debt to equity: 0.029132830609833925
Current ratio: 6.331325704679332
Quick ratio: 6.331325704679332
Effective tax rate (%): 25.615354910682363
Interest coverage ratio: 105.71044921874999
COGS to revenue (%): 39.069861576243056
Buyback yield (%): 0
Receivables turnover: 1.7102161925579795
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 7.074642414588195
Revenue growth (%): 39.9177766010853
Rule of 40 score: 39.9177766010853
Financial ratios for CARERATING.NS — quarterly report dated 2025-12-31
Total revenue: 12490163.751810182
Gross profit: 6434042.55319149
Operating income: 4082722.5130890054
Net income: 4070357.580483458
Capital expenditures: 0
Depreciation & amortization: 411172.9976606884
Owner earnings: 4481530.578144146
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 17.67361033752924
P/E ratio: 28.449247333868176
Shares outstanding: 30087146
Market cap (USD): 531748494.5723515
Effective tax rate (%): 25.419951095852944
Interest coverage ratio: 56.646986089644514
COGS to revenue (%): 48.487124099882095
Buyback yield (%): 0
Capitalized R&D asset: 0
Revenue growth (%): -18.760094713208066
Rule of 40 score: -18.760094713208066
Financial ratios for CBKD.L — annual report dated 2021-12-31
Capital expenditures: 0
Depreciation & amortization: 3292283.163265306
Buffett classification: The Gruesome
Stock price: 0.023513513513513513
Shares outstanding: 3299278100
Market cap (USD): 77577620.18918918
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBKD.L — annual report dated 2022-12-31
Total revenue: 1472295392.0776072
Net income: 653684316.8957155
Capital expenditures: 41685165.72352466
Operating cash flow: 2623385084.882781
Depreciation & amortization: 37891026.677445434
Net tangible assets: 2733924050.121261
Owner earnings: 649890177.8496362
Return on net tangible assets (%): 23.771332558445096
Buffett classification: The Gruesome
Stock price: 0.011807228915662651
P/E ratio: 0.05959349303059264
Shares outstanding: 3299278100
Book value: 2762254163.2983017
P/B ratio: 0.01410273258005247
Market cap (USD): 38955331.78313253
Debt to equity: 0.15270503007923775
Effective tax rate (%): 32.45078814897411
COGS to revenue (%): 0
SG&A to revenue (%): 9.068909715602
Free cash flow (dilution-adjusted): 2552347736.4591756
Buyback yield (%): 0
Retained earnings: 662645149.5553759
Receivables turnover: 3.1959940864885703
Capitalized R&D asset: 0
FCF margin (%): 173.35840010050353
Rule of 40 score: 173.35840010050353
Financial ratios for CBKD.L — annual report dated 2023-12-31
Total revenue: 1941995467.7889285
Net income: 960468274.5224992
Capital expenditures: 54521948.850760765
Operating cash flow: 5642764940.110068
Depreciation & amortization: 29416154.095176432
Net tangible assets: 2929148365.1667204
Owner earnings: 935362479.7669148
Return on net tangible assets (%): 31.932915754292157
Buffett classification: The Gruesome
Stock price: 0.013417721518987341
P/E ratio: 0.04609084540715526
Shares outstanding: 3299278100
Book value: 2934330398.1871147
P/B ratio: 0.015086506545699072
Market cap (USD): 44268794.75949367
Debt to equity: 0.17163508807326666
Effective tax rate (%): 28.67092180025853
COGS to revenue (%): 0
SG&A to revenue (%): 6.834812956672841
Free cash flow (dilution-adjusted): 5563753512.46358
Buyback yield (%): 0
Retained earnings: 970972191.6477824
Receivables turnover: 3.7347285029842596
Capitalized R&D asset: 0
FCF margin (%): 286.49673002575173
Revenue growth (%): 31.90257051939226
Rule of 40 score: 318.399300545144
Financial ratios for CBKD.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Depreciation & amortization: 0
Buffett classification: The Gruesome
Stock price: 0.018933333333333333
Shares outstanding: 3299278100
Market cap (USD): 62466332.02666666
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBKD.L — quarterly report dated 2024-12-31
Total revenue: 285581263.530801
Net income: 254060893.52489665
Capital expenditures: 66865065.93190317
Operating cash flow: -1198032788.821098
Depreciation & amortization: 6206140.523518992
Net tangible assets: 3004059771.6984844
Owner earnings: 193401968.11651248
Return on net tangible assets (%): 6.438019973456244
Buffett classification: The Gruesome
Stock price: 0.015499999999999998
P/E ratio: 0.05032141098191944
Shares outstanding: 3299278100
Book value: 3007662290.887619
P/B ratio: 0.017002843272975285
Market cap (USD): 51138810.55
Debt to equity: 0.18996400330819435
Effective tax rate (%): 30.275931324393014
COGS to revenue (%): 0
SG&A to revenue (%): -22.351138329626565
Free cash flow (dilution-adjusted): -1268853867.3489468
Buyback yield (%): 0
Retained earnings: 1117730427.081283
Receivables turnover: 0.3889974591712262
Capitalized R&D asset: 0
FCF margin (%): -444.30571237811483
Rule of 40 score: -444.30571237811483
Financial ratios for CBKD.L — annual report dated 2024-12-31
Total revenue: 2048059043.495375
Net income: 1087516866.758512
Capital expenditures: 114076717.18165715
Operating cash flow: 1766665813.8161778
Depreciation & amortization: 21224424.325920094
Net tangible assets: 3004059771.6984844
Owner earnings: 994664573.9027749
Return on net tangible assets (%): 33.110678531552495
Buffett classification: The Gruesome
Stock price: 0.015499999999999998
P/E ratio: 0.04702346429111117
Shares outstanding: 3299278100
Book value: 3007662290.887619
P/B ratio: 0.017002843272975285
Market cap (USD): 51138810.55
Debt to equity: 0.18996400330819435
Effective tax rate (%): 28.3642363265414
COGS to revenue (%): 0
SG&A to revenue (%): 5.705653213261186
Free cash flow (dilution-adjusted): 1632758433.379256
Buyback yield (%): 0
Retained earnings: 1117730427.081283
Receivables turnover: 2.78971300253536
Capitalized R&D asset: 0
FCF margin (%): 79.72223450124099
Revenue growth (%): 5.461576891690987
Rule of 40 score: 85.18381139293197
Financial ratios for CBKD.L — quarterly report dated 2025-03-31
Total revenue: 539841704.5679257
Net income: 328913763.1006526
Capital expenditures: 71018014.63318172
Operating cash flow: 3050133478.346846
Depreciation & amortization: 15285782.084239667
Net tangible assets: 3123415028.673126
Owner earnings: 273181530.5517105
Return on net tangible assets (%): 8.746244992864817
Buffett classification: The Gruesome
Stock price: 0.016363636363636365
P/E ratio: 0.04103521435373008
Shares outstanding: 3299278100
Book value: 3128683844.176388
P/B ratio: 0.01725587811993233
Market cap (USD): 53988187.09090909
Debt to equity: 0.18325132999474872
Effective tax rate (%): 26.731143603649336
COGS to revenue (%): 0
SG&A to revenue (%): 14.404595345862486
Free cash flow (dilution-adjusted): 2972744275.262013
Buyback yield (%): 0
Retained earnings: 730489183.310263
Receivables turnover: 0.8964255861353904
Capitalized R&D asset: 0
FCF margin (%): 550.669622244416
Revenue growth (%): 89.0326059537522
Rule of 40 score: 639.7022281981682